Orforglipron, a once-daily tablet produced by the same manufacturers as Mounjaro, has been given the green light by British health officials.

My wife, who works with these drugs, tells me that the current average BMI for NHS patients getting tirzepatide – Mounjaro – is 46.

Orforglipron, a once-daily tablet produced by the same manufacturers as Mounjaro, has been given the green light by British health officials.

The UK has become the first country in Europe to authorise orforglipron, known as Foundayo

Britain's regulator approved Eli Lilly's Foundayo pill for weight and diabetes. This treatment is not yet available through the NHS in the UK. Foundayo will launch privately…

Foundayo has been approved for treating weight loss as well as type 2 diabetes